Latest Breaking News On - Arch biopartners inc stock exchange - Page 1 : comparemela.com

TORONTO, April 18, 2023 Today, Arch Biopartners Inc., , a clinical stage company focused on the development of novel therapeutics targeting organ inflammation, announced that it has safely. | April 18, 2023

United statesRichard muruveVenture exchangeArch biopartners incRegulation services providerGlobenewswire incBiopartners incInvestigational new drug applicationDrug product manufacturingArch biopartnerCanadian securities administrator systemElectronic document analysisChief scienceArch biopartners inc stock exchangePress releaseAs achff ca03938c1041